Co-Diagnostics, Inc. (CODX)
1.11
+0.02
(+1.83%)
USD |
NASDAQ |
Oct 09, 11:41
Co-Diagnostics Max Drawdown (5Y) : 99.70% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 99.70% |
| August 31, 2026 | 99.67% |
| July 31, 2026 | 99.62% |
| June 30, 2026 | 99.62% |
| May 31, 2026 | 99.62% |
| April 30, 2026 | 99.60% |
| March 31, 2026 | 99.60% |
| February 28, 2026 | 99.60% |
| January 31, 2026 | 99.59% |
| December 31, 2025 | 99.25% |
| November 30, 2025 | 99.25% |
| October 31, 2025 | 99.25% |
| September 30, 2025 | 99.25% |
| August 31, 2025 | 99.25% |
| July 31, 2025 | 99.25% |
| June 30, 2025 | 99.25% |
| May 31, 2025 | 99.25% |
| April 30, 2025 | 99.03% |
| March 31, 2025 | 98.99% |
| February 28, 2025 | 98.39% |
| January 31, 2025 | 97.73% |
| December 31, 2024 | 97.73% |
| November 30, 2024 | 97.11% |
| October 31, 2024 | 96.75% |
| September 30, 2024 | 96.75% |
| Date | Value |
|---|---|
| August 31, 2024 | 96.75% |
| July 31, 2024 | 96.75% |
| June 30, 2024 | 96.75% |
| May 31, 2024 | 96.75% |
| April 30, 2024 | 96.75% |
| March 31, 2024 | 96.75% |
| February 29, 2024 | 96.75% |
| January 31, 2024 | 96.75% |
| December 31, 2023 | 96.75% |
| November 30, 2023 | 96.75% |
| October 31, 2023 | 96.75% |
| September 30, 2023 | 96.66% |
| August 31, 2023 | 96.62% |
| July 31, 2023 | 96.62% |
| June 30, 2023 | 96.62% |
| May 31, 2023 | 96.53% |
| April 30, 2023 | 95.71% |
| March 31, 2023 | 95.49% |
| February 28, 2023 | 92.47% |
| January 31, 2023 | 92.47% |
| December 31, 2022 | 92.47% |
| November 30, 2022 | 90.68% |
| October 31, 2022 | 90.68% |
| September 30, 2022 | 90.68% |
| August 31, 2022 | 89.40% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Fractyl Health, Inc. | -- |
| Spectral AI, Inc. | 93.49% |
| Quantum-Si, Inc. | 97.18% |
| Arrowhead Pharmaceuticals, Inc. | 88.96% |
| Omnicell, Inc. | 86.59% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -100.19 |
| Beta (5Y) | 2.896 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 145.2% |
| Historical Sharpe Ratio (5Y) | -0.4906 |
| Historical Sortino (5Y) | -1.333 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 48.80% |